Abstract
Purpose
The purpose of this study is to assess the efficacy of moxibustion as a treatment of chemotherapy-induced leukopenia.
Methods
Twelve databases were searched from their inception through June 2014, without a language restriction. Randomized clinical trials (RCTs) were included if moxibustion was used as the sole treatment or as a part of a combination therapy with conventional drugs for leukopenia induced by chemotherapy. Cochrane criteria were used to assess the risk of bias.
Results
Six RCTs with a total of 681 patients met our inclusion criteria. All of the included RCTs were associated with a high risk of bias. The trials included patients with various types of cancer receiving ongoing chemotherapy or after chemotherapy. The results of two RCTs suggested the effectiveness of moxibustion combined with chemotherapy vs. chemotherapy alone. In four RCTs, moxibustion was more effective than conventional drug therapy. Six RCTs showed that moxibustion was more effective than various types of control interventions in increasing white blood cell counts.
Conclusions
There is low level of evidence based on these six trials that demonstrates the superiority of moxibustion over drug therapies in the treatment of chemotherapy-induced leukopenia. However, the number of trials, the total sample size, and the methodological quality are too low to draw firm conclusions. Future RCTs appear to be warranted.
Similar content being viewed by others
References
World Health Organization (2014) Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/ Accessed 10 June 2014
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M (2007) Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma. Br J Cancer 97:37–42
Liu W, Zhang CC, Li K (2013) Prognostic value of chemotherapy-induced leukopenia in small-cell lung cancer. Cancer Biol Med 10:92–98
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad I, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:56–93
Clark OA, Lyman GH, Castro AA, Clark LG, Djulbegovic B (2005) Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials. J Clin Oncol 23:4198–4214
Dale DC (2009) Advances in the treatment of neutropenia. Curr Opin Support Palliat Care 3:207–212
Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, European Organisation for Research and Treatment of Cancer (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47:8–32
Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8:477–485
World Health Organization (2007) WHO international standard terminologies on traditional medicine in the western pacific region. World Health Organization, Western Pacific Region, Manila, Philippines
World Health Organization Western Pacific Region (2007) WHO international standard terminologies on traditional medicine in the western pacific region. Manila
Deng H, Shen X (2013) The mechanism of moxibustion: ancient theory and modern research. Evid Based Complement Alternat Med 2013:379291
Yang HQ, Liu XG, Yang X, Chen T, Yu SG (2013) Effect of different types of moxibustion intervention on expression of inflammatory cytokines IL-1 and TNF-alpha in rabbits with rheumatoid arthritis. Zhen Ci Yan Jiu 38:134–139
Zhang JL, Li SS, Luo WH, Zhang DF, Shu RG (2008) Research of moxibustion therapy for cancer: a review. Jiangxi J Tradit Chin Med 39:59–61
Lee MS, Choi TY, Park JE, Lee SS, Ernst E (2010) Moxibustion for cancer care: a systematic review and meta-analysis. BMC Cancer 10:130
Pei J, Yu YM, Wei H, Fang ZQ, Guan DY, Yu QW (2007) Experimental research on moxibustion in modulating tumor immunosuppression. Shanghai J Tradit Chin Med 41:1–4
Cui J, Yan J (2007) Effect of moxibustion or acupuncture at Geshu acupoint on the granulocyte-macrophage colony stimulating factor of cyclophosphamide induced leukopenic rats. J Clin Rehabil Tissue Eng Res 11:5473–5476
Yang HY, Hu ZC (2010) Biophysical characteristics of moxibustion. World J Acupunct Moxibustion 20(27–31):37
Lu J, Zhang HL, Yin ZZ, Tu Y, Li ZG, Zhao BX, Guo JY (2012) Moxibustion attenuates inflammatory response to chronic exhaustive exercise in rats. Int J Sports Med 33:580–585
Zhao XX, Hang XM, Wang HP, Lu M, Yu TK (2011) Effect of acupuncture-moxibustion on bone marrow suppression and leukocytes after chemotherapy. J Acupunct Tuina Sci 9:331–335
Li Y, Li P (2010) The research progress of acupuncture in the treatment of leukopenia after radiotherapy and chemotherapy. Gansu J Tradit Chin Med 23:71–73
Lee MS, Kim T-H, Ernst E (2012) Is acupuncture or moxibustion better than a sham or placebo-treatment? In: Cho WCS (ed) Acupuncture and moxibustion as an evidence-based therapy for cancer. Springer Netherlands, pp. 249-264
Choi T-Y, Lee M, Ernst E (2012) An overview of acupuncture and moxibustion for cancer care. In: Cho WCS (ed) Acupuncture and Moxibustion as an evidence-based therapy for cancer. Springer Netherlands, pp. 1-18
Zhang HW, Lin ZX, Cheung F, Cho WCS, Tang JL (2013) Moxibustion for alleviating side effects of chemotherapy or radiotherapy in cancer patients (Protocol). Cochrane Database Syst Rev. doi:10.1002/14651858.CD010559
Lu W, Hu D, Dean-Clower E, Doherty-Gilman A, Legedza AT, Lee H, Matulonis U, Rosenthal DS (2007) Acupuncture for chemotherapy-induced leukopenia: exploratory meta-analysis of randomized controlled trials. J Soc Integr Oncol 5:1–10
Higgins JPT, Altman DG, Sterne JAC (2011) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 510. The Cochrane Collaboration,http://www.cochrane-handbook.org, Accessed 28 May 2014
Wu YT, Wu JY, Yue HP (2013) Observation on thermal moxibustion on myelosuppression induced by chemotherapy in patients with malignant tumor. Liaoning J Tradit Chin Med 40:2120–2121
Shao KW, Kong YM (2012) Clinical study on herbs-partitioned moxibustion treatment of after chemotherapy with leukopenia in 82 cases. Hunan J Tradit Chin Med 28:86–87
Li PH (2012) Clinical study on ginger moxibustion for the treatment of leukopenia after chemotherapy of cancer. China J Chin Med 27:1244–1245
Zhao XX, Lu M, Zhu X, Gao P, Li YL, Wang XM, Ma DY, Guo XH, Tong BY, Yang XL, Du WW, Zhou SF, Liu HM, Ran PF, Lu XR (2007) Multi-central clinical evaluation of ginger-partitioned moxibustion for treatment of leukopenia induced by chemotherapy. Chin Acupunct Moxibustion 27:715–720
Zhang Y, Luo YX, Caui XP, Hu H (2013) Clinical observation on the treatment of leukocytopenia after chemotherapy in 45 patients with malignant tumor receiving herbs-partitioned moxibustion. Pharm Clin Chin Mater Medica 4:42–43
Liang JJ, Luo GY, Du ZP (2012) Clinical observation on herbs-partitioned moxibustion prevention for gastrointestinal cancer with cause chemotherapy of bone marrow suppression. J Emerg Tradit Chin Med 21:1330–1331
Vickers A, Goyal N, Harland R, Rees R (1998) Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 19:159–166
Schulz KF (2001) Assessing allocation concealment and blinding in randomised controlled trials: why bother? Evid Based Nurs 4:4–6
Zhao B, Wang X, Lin Z, Liu R, Lao L (2006) A novel sham moxibustion device: a randomized, placebo-controlled trial. Complement Ther Med 14:53–60
Park JE, Lee SS, Lee MS, Choi SM, Ernst E (2010) Adverse events of moxibustion: a systematic review. Complement Ther Med 18:215–223
Moor A, McQuay H (2006) Bandolier’s little book of making sense of the medical evidence. Oxford University Press, Oxford
Schulz KF, Altman DG, Moher D, CONSORT Group (2011) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 9:672–677
MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D, STRICTA Revision Group (2010) Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med 3:140–155
Conflict of interest
None
Accessing the primary data
Our manuscript had no primary data, and all of the data came from primary research.
Author information
Authors and Affiliations
Corresponding author
Additional information
PROSPERO registration number: CRD42014009739
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Choi, TY., Lee, M.S. & Ernst, E. Moxibustion for the treatment of chemotherapy-induced leukopenia: a systematic review of randomized clinical trials. Support Care Cancer 23, 1819–1826 (2015). https://doi.org/10.1007/s00520-014-2530-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2530-7